TipRanks
Advertisement
Advertisement

ASMB Stock Latest News

Assembly Biosciences exercises profit share option with Gilead for HSV program
The FlyAssembly Biosciences exercises profit share option with Gilead for HSV program
9d ago
ASMB
GILD
Assembly Biosciences price target raised to $53 from $45 at Mizuho
PremiumThe Fly
Assembly Biosciences price target raised to $53 from $45 at Mizuho
16d ago
ASMB
Assembly Biosciences initiated with a Buy at UBS
PremiumThe Fly
Assembly Biosciences initiated with a Buy at UBS
16d ago
ASMB
Assembly Biosciences: Strategic Pipeline Expansion, Strong Cash Position Support Unchanged $50 Price Target and Buy Rating
PremiumRatings
Assembly Biosciences: Strategic Pipeline Expansion, Strong Cash Position Support Unchanged $50 Price Target and Buy Rating
1M ago
ASMB
Assembly Biosciences reports Q2 EPS (20c), consensus (52c)
PremiumThe Fly
Assembly Biosciences reports Q2 EPS (20c), consensus (52c)
1M ago
ASMB
Assembly Biosciences Inc (ASMB) Q2 Earnings Cheat Sheet
PremiumPre-EarningsAssembly Biosciences Inc (ASMB) Q2 Earnings Cheat Sheet
1M ago
ASMB
Assembly Biosciences price target raised to $45 from $40 at Mizuho
Premium
The Fly
Assembly Biosciences price target raised to $45 from $40 at Mizuho
3M ago
ASMB
Assembly Biosciences Expands Equity Plans, Reelects Board
Premium
Company Announcements
Assembly Biosciences Expands Equity Plans, Reelects Board
3M ago
8K
ASMB
Assembly Biosciences Completes Significant Equity Offering Financing
PremiumCompany Announcements
Assembly Biosciences Completes Significant Equity Offering Financing
4M ago
8K
ASMB
Assembly Biosciences Expands ABI-6250 Liver Disease Program
PremiumCompany Announcements
Assembly Biosciences Expands ABI-6250 Liver Disease Program
4M ago
8K
ASMB
Assembly Biosciences announces expansion of ABI-6250 clinical development
PremiumThe Fly
Assembly Biosciences announces expansion of ABI-6250 clinical development
4M ago
ASMB
Analyst Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target Amid Pipeline Progress and 2028 Cash Runway
PremiumRatings
Analyst Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target Amid Pipeline Progress and 2028 Cash Runway
4M ago
ASMB
Assembly Biosciences reports Q1 EPS (54c), consensus (64c)
PremiumThe FlyAssembly Biosciences reports Q1 EPS (54c), consensus (64c)
4M ago
ASMB
ASMB Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ASMB Earnings this Week: How Will it Perform?
5M ago
ASMB
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
Premium
The Fly
Assembly Biosciences price target raised to $43 from $39 at Guggenheim
5M ago
ASMB
GILD
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
PremiumCompany Announcements
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
6M ago
8K
ASMB
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
PremiumCompany Announcements
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
6M ago
ASMB
Assembly Biosciences files $400M mixed securities shelf
PremiumThe Fly
Assembly Biosciences files $400M mixed securities shelf
6M ago
ASMB
Is ASMB a Buy, Before Earnings?
PremiumPre-Earnings
Is ASMB a Buy, Before Earnings?
7M ago
ASMB
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
PremiumRatingsGilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
9M ago
ASMB
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
Premium
The Fly
Gilead opt-in ‘significantly de-risks’ Assembly pipeline, says H.C. Wainwright
9M ago
ASMB
GILD
Gilead exercises option to license Assembly helicase-primase inhibitor programs
Premium
The Fly
Gilead exercises option to license Assembly helicase-primase inhibitor programs
9M ago
ASMB
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >